BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22952867)

  • 1. Induction of histiocytic sarcoma in mouse skeletal muscle.
    Liu J; Hettmer S; Milsom MD; Hofmann I; Hua F; Miller C; Bronson RT; Wagers AJ
    PLoS One; 2012; 7(8):e44044. PubMed ID: 22952867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.
    Kemps PG; Hebeda KM; Pals ST; Verdijk RM; Lam KH; Bruggink AH; de Lil HS; Ruiterkamp B; de Heer K; van Laar JA; Valk PJ; Mutsaers P; Levin MD; Hogendoorn PC; van Halteren AG
    J Pathol Clin Res; 2021 Jan; 7(1):10-26. PubMed ID: 32852896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide analysis of acute leukemia and clonally related histiocytic sarcoma in a series of three pediatric patients.
    Bleeke M; Johann P; Gröbner S; Alten J; Cario G; Schäfer H; Klapper W; Khoury J; Pfister S; Müller I
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28074. PubMed ID: 31737984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Gpr125 in the myeloid sarcoma formation induced by cooperating MLL/AF10(OM-LZ) and oncogenic KRAS in a mouse bone marrow transplantation model.
    Fu JF; Yen TH; Chen Y; Huang YJ; Hsu CL; Liang DC; Shih LY
    Int J Cancer; 2013 Oct; 133(8):1792-802. PubMed ID: 23564351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases.
    Shao H; Xi L; Raffeld M; Feldman AL; Ketterling RP; Knudson R; Rodriguez-Canales J; Hanson J; Pittaluga S; Jaffe ES
    Mod Pathol; 2011 Nov; 24(11):1421-32. PubMed ID: 21666687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutations in histiocytic sarcoma identified by next generation sequencing.
    Liu Q; Tomaszewicz K; Hutchinson L; Hornick JL; Woda B; Yu H
    Virchows Arch; 2016 Aug; 469(2):233-41. PubMed ID: 27259537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis.
    Chang YI; You X; Kong G; Ranheim EA; Wang J; Du J; Liu Y; Zhou Y; Ryu MJ; Zhang J
    Leukemia; 2015 Sep; 29(9):1847-56. PubMed ID: 25801914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis.
    Koschmieder S; Göttgens B; Zhang P; Iwasaki-Arai J; Akashi K; Kutok JL; Dayaram T; Geary K; Green AR; Tenen DG; Huettner CS
    Blood; 2005 Jan; 105(1):324-34. PubMed ID: 15331442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAS (G12D) cooperates with AML1/ETO to initiate a mouse model mimicking human acute myeloid leukemia.
    Zhao S; Zhang Y; Sha K; Tang Q; Yang X; Yu C; Liu Z; Sun W; Cai L; Xu C; Cui S
    Cell Physiol Biochem; 2014; 33(1):78-87. PubMed ID: 24480914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment of AML Mouse Model by Transplantation of Hematopoietic Cells from MLL-AF9 Transgenic Mice].
    Long WY; Shen X; Xing S; Xiong GL; Wang HG; Yu ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1369-1374. PubMed ID: 34627412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia.
    Kim WI; Matise I; Diers MD; Largaespada DA
    Blood; 2009 Jan; 113(5):1086-96. PubMed ID: 18952898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs.
    Affolter VK; Moore PF
    Vet Pathol; 2002 Jan; 39(1):74-83. PubMed ID: 12102221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary histiocytic sarcoma may cause apparent persistence or recurrence of minimal residual disease in childhood acute lymphoblastic leukemia.
    Alten J; Klapper W; Leuschner I; Eckert C; Beier R; Vallo E; Krause M; Claviez A; Vieth S; Bleckmann K; Möricke A; Schrappe M; Cario G
    Pediatr Blood Cancer; 2015 Sep; 62(9):1656-60. PubMed ID: 25833113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells.
    Hettmer S; Liu J; Miller CM; Lindsay MC; Sparks CA; Guertin DA; Bronson RT; Langenau DM; Wagers AJ
    Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20002-7. PubMed ID: 22135462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma.
    Fernandez-Pol S; Bangs CD; Cherry A; Arber DA; Gratzinger D
    Hum Pathol; 2016 Sep; 55():39-43. PubMed ID: 27134111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biology.
    Dazzi F; Capelli D; Hasserjian R; Cotter F; Corbo M; Poletti A; Chinswangwatanakul W; Goldman JM; Gordon MY
    Blood; 1998 Aug; 92(4):1390-6. PubMed ID: 9694728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling.
    Kordes M; Röring M; Heining C; Braun S; Hutter B; Richter D; Geörg C; Scholl C; Gröschel S; Roth W; Rosenwald A; Geissinger E; von Kalle C; Jäger D; Brors B; Weichert W; Grüllich C; Glimm H; Brummer T; Fröhling S
    Leukemia; 2016 Apr; 30(4):937-46. PubMed ID: 26582644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
    Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
    Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of variables determining the engraftment potential of human acute myeloid leukemia in the immunodeficient NOD/SCID human chimera model.
    Rombouts WJ; Martens AC; Ploemacher RE
    Leukemia; 2000 May; 14(5):889-97. PubMed ID: 10803522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.